DoorDash Inc vs Revvity Inc — how do they compare? DoorDash Inc trades at $211.85 (market cap $91.86B), while Revvity Inc trades at $115.76 (market cap $12.91B). The key difference: DoorDash Inc is far larger — about 7.1× Revvity Inc's market cap, and Revvity Inc pays a 0.24% dividend while DoorDash Inc pays none. Which is the better fit depends on your goals.
| DASH | RVTY | |
|---|---|---|
Market Cap | $91.86B | $12.91B |
Sector | Consumer Cyclical | Technology |
52-Week High | $281.74 | $117.75 |
52-Week Low | $146.60 | $82.26 |
Enterprise Value | $89.82B | $15.23B |
Dividend Yield | — | 0.24% |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 2013 and headquartered in San Francisco, DoorDash is an online food order demand aggregator. Consumers can use its app to order food on-demand for pickup or delivery from merchants mainly in the U.S. The firm provides a marketplace for the merchants to create a presence online, market their offerings, and meet demand by making the offerings available for pickup or delivery. The firm provides similar service to businesses in addition to restaurants, such as grocery, retail, pet supplies, and flowers. At the end of 2020, DoorDash had over 450,000 merchants, 20 million consumers, and over 1 million dashers on its platform. In 2020, the firm generated $24.7 billion in gross order volume (up 207% year over year) and $2.9 billion in revenue (up 226%).
Read more on DASH →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →